Captii Limited (SGX:AWV)

CTI BioPharma Balance Sheet

Financials in millions SGD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	11.5	10.03	10.97	13.22	13.82	13.15
Cash & Short-Term Investments	11.5	10.03	10.97	13.22	13.82	13.15
Cash Growth	23.66%	-8.49%	-17.08%	-4.34%	5.14%	29.23%
Accounts Receivable	9.72	11.28	9.08	10.3	9.26	7.76
Other Receivables	-	-	-	0	0.1	0.32
Receivables	9.72	11.28	9.08	10.3	9.36	8.08
Inventory	0.01	0.01	0.01	0.01	0	0
Prepaid Expenses	-	0.28	0.52	0.54	0.5	0.41
Other Current Assets	1.63	2.73	3.68	3.81	3.54	3.7
Total Current Assets	22.86	24.33	24.26	27.87	27.23	25.34
Property, Plant & Equipment	1.05	3.34	3.09	3.22	3.95	4.76
Long-Term Investments	-	10.93	17.17	23.9	28.52	13.83
Goodwill	-	-	2.1	6.58	9.89	10.06
Long-Term Accounts Receivable	-	-	-	-	-	0.28
Long-Term Deferred Tax Assets	0.78	0.78	0.65	0.8	1.03	0.92
Long-Term Deferred Charges	-	0.93	0.8	0.77	0.75	0.9
Total Assets	38.62	40.31	48.08	63.13	71.37	56.09
Accounts Payable	2.28	1.2	1.48	2	3.35	1.93
Accrued Expenses	-	1.4	1.51	1.88	2.62	1.5
Short-Term Debt	-	0.91	0.85	0.9	0.27	0.97
Current Portion of Leases	0.32	0.35	0.32	0.3	0.34	0.32
Current Income Taxes Payable	0.01	-	0.05	0.25	0.55	0.16
Current Unearned Revenue	-	0.32	0.46	0.48	0.71	1.19
Other Current Liabilities	0.49	0.28	0.37	0.43	0.39	0.36
Total Current Liabilities	3.1	4.46	5.03	6.25	8.23	6.43
Long-Term Leases	0.37	0.52	0.34	0.18	0.42	0.69
Long-Term Deferred Tax Liabilities	0.01	0.01	0.03	-	-	0.01
Total Liabilities	3.48	4.99	5.41	6.43	8.65	7.13
Common Stock	31.95	31.95	31.95	31.95	31.95	31.95
Retained Earnings	8.76	9.01	15.95	24.77	28.67	20
Comprehensive Income & Other	-10.5	-10.52	-11.76	-10.39	-8.65	-8.16
Total Common Equity	30.21	30.43	36.14	46.32	51.97	43.78
Minority Interest	4.93	4.88	6.53	10.38	10.75	5.18
Shareholders' Equity	35.14	35.31	42.67	56.71	62.72	48.96
Total Liabilities & Equity	38.62	40.31	48.08	63.13	71.37	56.09
Total Debt	0.69	1.78	1.51	1.37	1.03	1.99
Net Cash (Debt)	10.81	8.26	9.46	11.85	12.79	11.16
Net Cash Growth	22.83%	-12.70%	-20.18%	-7.36%	14.59%	32.13%
Net Cash Per Share	-	0.26	0.30	0.37	0.40	0.35
Filing Date Shares Outstanding	-	31.96	31.96	31.96	31.96	31.96
Total Common Shares Outstanding	-	31.96	31.96	31.96	31.96	31.96
Working Capital	19.76	19.87	19.23	21.62	19	18.91
Book Value Per Share	-	0.95	1.13	1.45	1.63	1.37
Tangible Book Value	29.2	30.43	34.05	39.75	42.08	33.72
Tangible Book Value Per Share	-	0.95	1.07	1.24	1.32	1.06
Machinery	-	9.12	8.75	9.13	9.67	9.75

Updated Feb 20, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.